FISHER + PAYKEL HEALTH.
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The com… Read more
FISHER + PAYKEL HEALTH. (FPLB) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, FISHER + PAYKEL HEALTH. (FPLB) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
FISHER + PAYKEL HEALTH. - Net Assets Trend (None–None)
This chart illustrates how FISHER + PAYKEL HEALTH.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for FISHER + PAYKEL HEALTH. (None–None)
The table below shows the annual net assets of FISHER + PAYKEL HEALTH. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to FISHER + PAYKEL HEALTH.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
FISHER + PAYKEL HEALTH. Competitors by Market Cap
The table below lists competitors of FISHER + PAYKEL HEALTH. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Synnex Corporation
NYSE:SNX
|
$11.51 Billion |
|
Advanced Energy Industries Inc
NASDAQ:AEIS
|
$11.51 Billion |
|
JSW Steel Limited
NSE:JSWSTEEL
|
$11.52 Billion |
|
Samsung Fire & Marine Insurance
KO:000810
|
$11.53 Billion |
|
SITC International Holdings Company Limited
PINK:SITIY
|
$11.47 Billion |
|
Dynatrace Holdings LLC
NYSE:DT
|
$11.46 Billion |
|
Catalent Inc
NYSE:CTLT
|
$11.45 Billion |
|
Kerry Group
IR:KRZ
|
$11.45 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in FISHER + PAYKEL HEALTH.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares FISHER + PAYKEL HEALTH.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently FISHER + PAYKEL HEALTH. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares FISHER + PAYKEL HEALTH.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $9,394,036,854
- Average return on equity (ROE) among peers: 4.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| FISHER + PAYKEL HEALTH. (FPLB) | €- | N/A | N/A | $11.49 Billion |
| Modern Dental Group Limited (1MD) | $2.36 Billion | 15.30% | 0.55x | $193.75 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $482.88 Million |
| Alcon Inc. (2U3) | $19.26 Billion | 1.95% | 0.45x | $33.73 Billion |
| Shofu Inc. (69W) | $35.51 Billion | 8.83% | 0.23x | $215.32 Million |
| 7VG (7VG) | $176.36 Million | 14.92% | 1.12x | $684.88 Million |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $2.79 Million |
| Paul Hartmann AG (PHH2) | $690.37 Million | 10.65% | 0.81x | $776.29 Million |
| Sartorius AG VZO O.N. (SRT) | $497.08 Million | 9.76% | 1.56x | $6.78 Billion |
| Shandong Weigao Group Medical Polymer Company Limited (UK2) | $25.34 Billion | 8.16% | 0.37x | $1.36 Billion |